Degenerative Joint Disease
0
Pipeline Programs
4
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
StrykerCA - San Jose
2 programsTrident Acetabular X3 InsertN/A1 trial
Trident X3 Insert with Navigation systemN/A1 trial
Active Trials
Innovation PharmaceuticalsMA - Wakefield
1 programHip Innovation Technology Reverse Hip Replacement SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Innovation PharmaceuticalsHip Innovation Technology Reverse Hip Replacement System
StrykerTrident X3 Insert with Navigation system
StrykerTrident Acetabular X3 Insert
MedtronicPEAK PlasmaBlade 4.0
Zimmer BiometTotal Hip Arthroplasty
Clinical Trials (5)
Total enrollment: 665 patients across 5 trials
Safety and Effectiveness of the HIT Reverse HRS
Start: Jul 2022Est. completion: Jul 2035288 patients
N/ARecruiting
Navigation With X3 vs Non-Navigation With X3 Study
Start: Apr 2015Est. completion: Jul 201749 patients
N/ACompleted
Large Head X3 Study
Start: Jul 2010Est. completion: Jul 2019120 patients
N/AUnknown
PEAK PlasmaBlade 4.0 Versus Traditional Electrosurgery in Total Knee Replacement.
Start: Jun 2010Est. completion: Sep 201124 patients
N/ATerminated
A Study on M2a Magnum Total Hip Arthroplasty
Start: Nov 2009Est. completion: Apr 2017184 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 665 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.